Healthcare & Life Sciences
Kainova Therapeutics
Kainova Therapeutics is a Healthcare & Life Sciences startup based in Canada, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Kainova Therapeutics
Kainova Therapeutics is a company headquartered in Canada. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Kainova Therapeutics is a clinical-stage biotechnology company developing therapies that target G protein-coupled receptors (GPCRs) for the treatment of immuno-oncology and inflammatory diseases, with lead programs including antibodies and small molecules at various clinical stages.
Explore Kainova Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.